Ionis to Hold Q4 and Full Year 2025 Financial Results Webcast

Biotech firm to discuss progress on key programs in live online event.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

Ionis Pharmaceuticals, Inc. announced that it will host a live webcast on Wednesday, February 25 at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2025 financial results and highlight progress on key programs.

Why it matters

As a leading biotech company focused on RNA-targeted medicines, Ionis' quarterly and annual financial updates provide insights into the performance and pipeline of its innovative drug development efforts in areas like neurology and cardiometabolic disease.

The details

The webcast will be accessible on Ionis' investor relations website, and a replay will be available for a limited time. Ionis has been a pioneer in RNA therapies for three decades, with a focus on bringing new treatments to people with serious diseases.

  • The webcast will be held on Wednesday, February 25, 2026 at 11:30 a.m. Eastern Time.

The players

Ionis Pharmaceuticals, Inc.

A biotechnology company that has invented medicines focused on bringing better futures to people with serious diseases, with a leading pipeline in neurology, cardiometabolic disease and other high patient need areas.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be able to access the webcast replay to review Ionis' Q4 and full year 2025 financial performance and pipeline updates.

The takeaway

As a pioneer in RNA-targeted medicines, Ionis continues to drive innovation in this field and advance new approaches to address serious diseases, making its quarterly and annual updates important for understanding the company's progress.